In Brief
- Audrey Zheng developed a pancreatic cancer detection test with 87% accuracy.
- Her test identifies patients early, offering potential for improved survival.
- She is a national finalist in a prestigious science competition.
- The test isolates tumor particles via magnetic beads from blood samples.
Seventeen-year-old Audrey Zheng, a high school student from Pennsylvania, developed a pioneering early detection test for pancreatic cancer. Her method isolates tumor-derived particles from blood samples using magnetic beads, demonstrating an accuracy rate of 87% in identifying patients with the disease.
Additionally, the test correctly identified 87.5% of individuals without pancreatic cancer, indicating its reliability in differentiating between healthy and affected patients. This breakthrough offers promising potential for diagnosing pancreatic cancer at earlier stages, which is critical for improving treatment outcomes and survival rates.
Zheng's research and innovation earned her a place as a national finalist in a prestigious science competition.
